Frontiers | The Role of Ceramides in Insulin Resistance | Endocrinology
Frontiers | The Role of Ceramides in Insulin Resistance | Endocrinology
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
Welcome to Scientific Archives | Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS.
Metabolic Messengers: ceramides | Nature Metabolism
![PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/521ffada53075bca162dc03055312c91e84afbd6/8-Table1-1.png "PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar")
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels | Nature Communications
PDF) On ceramides, other sphingolipids and impaired glucose homeostasis☆
The Path to Insulin Resistance: Paved with Ceramides?: Cell Metabolism
Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance. - Nat. Commun. - X-MOL
Metabolic Messengers: ceramides | Nature Metabolism
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer | Nature Communications
Frontiers | The Role of Ceramides in Insulin Resistance | Endocrinology
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism | Nature Communications
Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus: Trends in Endocrinology & Metabolism
On ceramides, other sphingolipids and impaired glucose homeostasis - ScienceDirect
Genetic deletion of mast cell serotonin synthesis prevents the development of obesity and insulin resistance. - Nat. Commun. - X-MOL
Frontiers | The Role of Ceramides in Insulin Resistance | Endocrinology
Insulin action and resistance in obesity and type 2 diabetes | Nature Medicine
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML
P053 selectively reduces C18 sphingolipids in cultured cells. a... | Download Scientific Diagram
PDF) SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
![PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/521ffada53075bca162dc03055312c91e84afbd6/10-Table1-1.png "PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar")